SCHEMBL6069477

SCHEMBL6069477

Nc1cccc2c1c(Br)nn2CCN1CCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 7/20 0.41
▸ BCHE P06276 6/20 0.41
▸ CNR1 P21554 6/20 0.41
▸ SIGMAR1 Q99720 2/20 0.35
▸ KDR P35968 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ HRH1 P35367 2/20 0.34
▸ LTA4H P09960 1/20 0.34
▸ NPSR1 Q6W5P4 3/20 0.34
▸ POLB P06746 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ AHR P35869 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070650 0.83 CNR2 (0.41) CNR2BCHECNR1SIGMAR1KDR
SCHEMBL10831687 0.75 BCHE (0.54) CNR2BCHECNR1SIGMAR1HRH1
SCHEMBL6069256 0.73 BCHE (0.47) CNR2BCHECNR1SIGMAR1LTA4H
SCHEMBL6069486 0.72 CNR2 (0.54) CNR2BCHECNR1SIGMAR1LTA4H
SCHEMBL6069778 0.71 SIGMAR1 (0.50) CNR2BCHECNR1SIGMAR1
SCHEMBL6069255 0.70 SIGMAR1 (0.52) CNR2BCHECNR1SIGMAR1
SCHEMBL15552006 0.70 CSF1R (0.48) MAPTMEN1KMT2ACYP2C19KDM4E
SCHEMBL10831065 0.70 BCHE (0.54) CNR2BCHECNR1SIGMAR1HRH1
SCHEMBL11204616 0.70 BCHE (0.54) CNR2BCHECNR1SIGMAR1HRH1
SCHEMBL10831360 0.69 BCHE (0.45) CNR2BCHECNR1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7071182-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-07-04 — — US disclosed
US-20050277638-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-12-15 — — US disclosed
US-20050137243-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137243-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R CNR2 1318/4885BCHE 1148/4885CNR1 763/4885
US-20050277638-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R CNR2 1318/4885BCHE 1148/4885CNR1 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback